Table of Contents Table of Contents
Previous Page  673 692 Next Page
Information
Show Menu
Previous Page 673 692 Next Page
Page Background

[20]

Delahunt B, Cheville JC, Martignoni G, et al. The International Society of Urological Pathology (ISUP) grading system for renal cell carcino- ma and other prognostic parameters. Am J Surg Pathol 2013;37: 1490–504.

[21]

Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. Eur Urol 2016;70:93–105.

[22]

Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representa- tions of old estimators. Stat Med 1999;18:695–706.

[23]

Li P, Wong YN, Armstrong K, et al. Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras. Cancer Med 2016;5:169–81.

[24]

Leibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003;97:1663–71.

[25]

Hakimi AA, Chen YB, Wren J, et al. Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. Eur Urol 2013;63:848–54

.

[26]

Kapur P, Pena-Llopis S, Christie A, et al. Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation. Lancet Oncol 2013;14:159–67

.

[27]

Parker AS, Leibovich BC, Lohse CM, et al. Development and evaluation of BioScore: a biomarker panel to enhance prognostic algorithms for clear cell renal cell carcinoma. Cancer 2009;115: 2092–103

.

[28]

Liu Z, Liu Y, Xu L, et al. P2X7 receptor predicts postoperative cancer- specific survival of patients with clear-cell renal cell carcinoma. Cancer Sci 2015;106:1224–31.

[29]

Sim SH, Messenger MP, Gregory WM, et al. Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma. Br J Cancer 2012;107:1131–7

.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 6 6 5 – 6 7 3

673